Market Overview

UPDATE: Jefferies & Company Upgrades Health Net to Hold, Raises PT

Share:
Related HNT
Earnings Scheduled For May 4, 2015
Biotech Bubble Valuations From Sam Islay
Health Net's (HNT) CEO Jay Gellert on Q1 2015 Results - Earnings Call Transcript (Seeking Alpha)

In a report published Friday, Jefferies & Company upgraded its rating on Health Net (NYSE: HNT) to Hold, and raised its price target from $17.00 to $26.00.

Jefferies noted, “HNT's pricing agreement with California officials is a substantial risk mitigator. It narrows downside earnings risk, improves 2013 EPS, and addresses two key risks (SPDs; Duals) that were elements of our Underperform thesis. HNT is also making progress on a third concern, Commercial performance. We are upgrading to Hold and raising our PT to $26 on the improved outlook. This note analyzes scenarios for 2013 EPS that range to mid-$2.”

Health Net closed on Thursday at $25.35.

Latest Ratings for HNT

DateFirmActionFromTo
May 2015BarclaysMaintainsHold
Mar 2015BarclaysMaintainsUnderweight
Feb 2015Deutsche BankMaintainsHold

View More Analyst Ratings for HNT
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Upgrades Analyst Ratings

 

Related Articles (HNT)

Around the Web, We're Loving...

Get Benzinga's Newsletters